216 related articles for article (PubMed ID: 8105167)
21. Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer.
Farinati F; Annoni G; Donato MF; Nardelli P; Bertozzo A; De Maria N; Zotti S; Salvagnini M; Martinez D; Naccarato R
J Gastroenterol Hepatol; 1990; 5(6):633-8. PubMed ID: 1966598
[TBL] [Abstract][Full Text] [Related]
22. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
[TBL] [Abstract][Full Text] [Related]
23. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases.
Collazos J; Díaz F
Clin Chim Acta; 1994 Jun; 227(1-2):37-43. PubMed ID: 7955420
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.
Savolainen ER; Goldberg B; Leo MA; Velez M; Lieber CS
Alcohol Clin Exp Res; 1984; 8(4):384-9. PubMed ID: 6385761
[TBL] [Abstract][Full Text] [Related]
25. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
26. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
27. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
29. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
30. Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C.
Giannini E; Caglieris S; Ceppa P; Risso D; Lantieri PB; Testa R
Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):137-41. PubMed ID: 11246612
[TBL] [Abstract][Full Text] [Related]
31. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
[TBL] [Abstract][Full Text] [Related]
32. [Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Matsuda H
Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):153-61. PubMed ID: 1851519
[TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
Sato S
Nihon Shokakibyo Gakkai Zasshi; 1992 Sep; 89(9):2007-15. PubMed ID: 1404988
[TBL] [Abstract][Full Text] [Related]
34. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
36. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
37. [Clinical value of virtual touch tissue quantification and PGA index in evaluation of alcoholic liver fibrosis].
Liu F; Wei L; Tang X; Wang S; Bao J; Zheng Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1246-52. PubMed ID: 26643430
[TBL] [Abstract][Full Text] [Related]
38. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
[TBL] [Abstract][Full Text] [Related]
39. Serum type III procollagen N-terminal peptide in coal miners.
Janssen YM; Engelen JJ; Giancola MS; Low RB; Vacek P; Borm PJ
Exp Lung Res; 1992; 18(1):1-8. PubMed ID: 1572317
[TBL] [Abstract][Full Text] [Related]
40. [Serial change in serum concentration of type III procollagen N-terminal peptide after TAE in hepatocellular carcinoma, and analysis of gel filtration pattern of the peptide].
Matsuda H; Takeda Y; Ueno T; Takeda R
Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2742-8. PubMed ID: 2560488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
